Numerous clinical trials are always active (ie, open and enrolling patients) in the ECOG-ACRIN Cancer Research Group, which focuses its research on adults who have or are at risk of developing cancer. The buttons below depict the general research categories being investigated in ECOG-ACRIN clinical trials. To access information within a particular category, click on the relevant button. Upon clicking, the color of the button will change from grey to red, and a table will appear on screen. The table will display the study number, study description, lead investigator(s), accrual goal, and the date the trial was activated (began enrolling patients). Please read the ECOG-ACRIN Disclaimer in its entirety before accessing this information.
To inquire about a particular trial, send us an email using our contact form. Alternatively, send an email to the study chair; click on their hyperlinked name and a new email window will open. To view educational materials, click on the links provided in the Educational Materials column.
Head and Neck Cancer Trials Currently Recruiting Participants
STUDY DESCRIPTION ECOG-ACRIN STUDY CHAIR
EA3132 Phase II Randomized Trial of Adjuvant Radiotherapy with or without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck Robert L. Ferris, MD, Ph D
Christine H. Chung, MD, Co-Chair
345 03/29/2016 EA3132 Resources
E3311 Phase II Randomized Trial of Transoral Surgical Resection followed by Low-dose or Standard-dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer Robert L. Ferris, MD, PhD
Harry Quon, MD, MS, Co-Chair
(Shuli Li, PhD)
377 07/09/2013 E3311 Resources
ACRIN 6685 A Multicenter Trial of FDG-PET/CT Staging of Head and Neck Cancer and its Impact on the N0 Neck Surgical Treatment in Head and Neck Cancer Patients Val J. Lowe, MD
Brendan C. Stack, Jr., MD, FACS, Co-Chair
Christopher S. Hollenbeak, PhD, Co-Chair
(Fenghai Duan, PhD)
292 04/01/2010 A6685 Resources